STARTUP WITH ONLY 3 M USD IN INVESTMENT TEAMS UP WITH TAKEDA for a license worth almost two zeros more if successful. Takeda has been at the lead of creative deal making, and this is a win-win. It reinforces that Big Pharma and early stage ventures can make great partners at the discovery end of the business.
http://lnkd.in/n8mmxC
linkedin post 2022-06-29 05:12:48
Nigel Fleming
September 21, 2022